Integra LifeSciences (IART) PT Lowered to $26 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Craig Bijou lowered the price target on Integra LifeSciences (NASDAQ: IART) to $26.00 (from $42.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
